<p>Wuxi Biologics (Cayman) Inc. has announced that its Board of Directors will hold a meeting on Tuesday, March 24, 2026. The purpose of the meeting includes considering and approving the annual results of the Group for the year ended December 31, 2025, as well as its publication. For more information, refer to the official announcement from the company. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi Biologics (Cayman) Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260211-12021320), on February 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

588250

159837

159859

Reuters

Penghua SSE STAR Biology and Medicine ETF

E Fund CSI Biotechnology Theme ETF

Tianhong CNI BIOMEDICINE ETF

E Fund CSI 300 Health Care ETF

Guotai CSI Bio-medicine ETF

Ping An CSI Medicine and Medical Device Innovation ETF

ChinaAMC SSE STAR Biology and Medicine ETF

Minsheng Royal CSI Biotechnology Theme ETF

Yinhua CSI Innovative Drugs Industry ETF

Founder Fubon CSI Medicine and Medical Device Innovation ETF

China Merchants CSI Biotechnology Theme ETF

Huaan Hang Seng Biotech ETF

WUXI BIO

WuXi Biologics

ChinaAMC CSI Biotechnology Theme ETF

ICBCCS SSE STAR Biology and Medicine ETF

ChinaAMC SSE Health Care ETF Initiating Fund

WuXi Biologics Board to Approve Annual Results